The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
Main Authors: | Prentice, C, Collins, R, Rodgers, A, MacMahon, S, Investigators, PEPT |
---|---|
Format: | Journal article |
Published: |
1999
|
Similar Items
Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)
by: Baigent, C, et al.
Published: (2009)
Similar Items
-
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
by: O'Brien, J, et al.
Published: (2000) -
PEP trial - Reply
by: Collins, R, et al.
Published: (2000) -
Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.
by: MacMahon, S, et al.
Published: (1994) -
Pulmonary embolism in pregnancy.
by: Patel, C, et al.
Published: (2010) -
No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients.
by: Neal, B, et al.
Published: (2000)